NAV
Explore a selection of essential drug information below, or:
Unlock enhanced features & extensive drug insights. Create a free account.
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

S-Arsonocysteine

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT
Full Drug Profiles
Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.
SUBSCRIBERECOMMENDED FOR PHARMA
Data Packages
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Generic Name
S-Arsonocysteine
DrugBank Accession Number
DB03352
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Similar Structures
Weight
Average: 245.086
Monoisotopic: 244.933914478
Chemical Formula
C3H8AsNO5S
Synonyms
  • S-Arsono-L-cysteine
  • S-Arsonocysteine
Unlock the secrets to drugging the undruggable
Discover how groundbreaking research is turning "undruggable" targets into therapeutic opportunities.
Download eBook
Unlock the secrets to drugging the undruggable
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UArsenate reductaseNot AvailableEscherichia coli
UProtein ArsCNot AvailableStaphylococcus aureus
U3-mercaptopyruvate sulfurtransferaseNot AvailableLeishmania major
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as l-cysteine-s-conjugates. These are compounds containing L-cysteine where the thio-group is conjugated.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
L-cysteine-S-conjugates
Alternative Parents
L-alpha-amino acids / Amino acids / Sulfenyl compounds / Organic metalloid salts / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives
show 1 more
Substituents
Aliphatic acyclic compound / Alpha-amino acid / Amine / Amino acid / Carbonyl group / Carboxylic acid / Hydrocarbon derivative / L-alpha-amino acid / L-cysteine-s-conjugate / Monocarboxylic acid or derivatives
show 12 more
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
XSWAJYRRDHPZDP-REOHCLBHSA-N
InChI
InChI=1S/C3H8AsNO5S/c5-2(3(6)7)1-11-4(8,9)10/h2H,1,5H2,(H,6,7)(H2,8,9,10)/t2-/m0/s1
IUPAC Name
(2R)-2-amino-3-(arsonosulfanyl)propanoic acid
SMILES
N[C@@H](CS[As](O)(O)=O)C(O)=O

References

General References
Not Available
PubChem Compound
17753924
PubChem Substance
46508550
ChemSpider
25057131
PDBe Ligand
CSR
PDB Entries
1jzw / 1lju / 1okg / 1sk1

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility40.4 mg/mLALOGPS
logP-3ALOGPS
logP-4.1Chemaxon
logS-0.78ALOGPS
pKa (Strongest Acidic)1.1Chemaxon
pKa (Strongest Basic)9.22Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area120.85 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity34.01 m3·mol-1Chemaxon
Polarizability17.38 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.5626
Blood Brain Barrier+0.6809
Caco-2 permeable-0.7012
P-glycoprotein substrateNon-substrate0.792
P-glycoprotein inhibitor INon-inhibitor0.9766
P-glycoprotein inhibitor IINon-inhibitor1.0
Renal organic cation transporterNon-inhibitor0.9629
CYP450 2C9 substrateNon-substrate0.8075
CYP450 2D6 substrateNon-substrate0.8176
CYP450 3A4 substrateNon-substrate0.7391
CYP450 1A2 substrateNon-inhibitor0.738
CYP450 2C9 inhibitorNon-inhibitor0.8589
CYP450 2D6 inhibitorNon-inhibitor0.9227
CYP450 2C19 inhibitorNon-inhibitor0.8592
CYP450 3A4 inhibitorNon-inhibitor0.8652
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9953
Ames testNon AMES toxic0.7379
CarcinogenicityNon-carcinogens0.7568
BiodegradationReady biodegradable0.7066
Rat acute toxicity2.0653 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.987
hERG inhibition (predictor II)Non-inhibitor0.9631
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00di-4900000000-52effd513a0a6f030d6f
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0190000000-489d5b3442f735ad600c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-0920000000-3aa853d9a5f03668bf0a
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9500000000-3d5d594d7b0544b5e1e6
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-0900000000-0841c886bce1dcab1704
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-00fr-9000000000-f51934181940031c99ea
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0kn9-2900000000-e561b3373d1a59885a8f
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Arsenate reductase
Kind
Protein
Organism
Escherichia coli
Pharmacological action
Unknown
General Function
Involved in resistance to arsenate (PubMed:3021763, PubMed:7577935, PubMed:8003492). Catalyzes the reduction of arsenate [As(V)] to arsenite [As(III)] (PubMed:14592722, PubMed:7577935, PubMed:8003492). The resulting arsenite is then extruded from the cell via the ArsAB transport system (Probable).
Specific Function
arsenate reductase (glutaredoxin) activity
Gene Name
arsC
Uniprot ID
P08692
Uniprot Name
Arsenate reductase
Molecular Weight
15830.1 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Details2. Protein ArsC
Kind
Protein
Organism
Staphylococcus aureus
Pharmacological action
Unknown
General Function
Catalyzes the reduction of arsenate [As(V)] to arsenite [As(III)] (PubMed:10606519, PubMed:11862551, PubMed:12072565, PubMed:12682056, PubMed:1409657, PubMed:16797027, PubMed:8003493). In vitro, has also low phosphatase activity with para-nitrophenyl phosphate (pNPP) as substrate (PubMed:11573087).
Specific Function
arsenate reductase (thioredoxin) activity
Gene Name
arsC
Uniprot ID
P0A006
Uniprot Name
Protein ArsC
Molecular Weight
14812.62 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Details3. 3-mercaptopyruvate sulfurtransferase
Kind
Protein
Organism
Leishmania major
Pharmacological action
Unknown
General Function
Not Available
Specific Function
3-mercaptopyruvate sulfurtransferase activity
Gene Name
MST
Uniprot ID
Q7K9G0
Uniprot Name
3-mercaptopyruvate sulfurtransferase
Molecular Weight
40154.325 Da

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52